Showing results (351-360 of 389) with videos related to

Sort By:
Pageof 39
BMC Gastroenterology|June 16, 2018
Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial)Arthur J A T Braat, Dik J Kwekkeboom, Boen L R Kam, et al.
European Journal of Endocrinology|May 9, 2019
Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATEWouter T Zandee, Richard A Feelders, Daan A Smit Duijzentkunst, et al.
The Journal of Clinical Endocrinology and Metabolism|August 7, 2015
No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1Sjoerd Nell, Rachel S van Leeuwaarde, Carolina R C Pieterman, et al.
Pituitary|December 11, 2012
Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's diseaseR van der Pas, C de Bruin, A M Pereira, et al.
Endocrine-Related Cancer|October 5, 2007
DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patientsY M H Jonkers, S M H Claessen, A Perren, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 2021
Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients: Results From the DutchMEN Study GroupMirthe J Klein Haneveld, Mark J C van Treijen, Carolina R C Pieterman, et al.
Neuroendocrinology|January 4, 2005
Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotidePhilippe Ruszniewski, Sofia Ish-Shalom, Machteld Wymenga, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2021
Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE studyNicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
The American Journal of Pathology|July 19, 2011
Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcomeDorian R A Swarts, Sandra M H Claessen, Yvonne M H Jonkers, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 2011
SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomasEsther Korpershoek, Judith Favier, José Gaal, et al.
Pageof 39